SEAS-developed cancer immunotherapies to be commercialized by … – Harvard School of Engineering and Applied Sciences
Harvard School of Engineering and Applied Sciences |
SEAS-developed cancer immunotherapies to be commercialized by …
Harvard School of Engineering and Applied Sciences A Wyss Institute researcher holds a device that can be loaded with immunotherapy agents designed to stimulate the immune system to attack tumor cells. (Image courtesy of the Wyss Institute at Harvard University). Made of the polymer that's used in … Novartis taps Harvard tech to advance cancer immunotherapy efforts Novartis, Harvard, Dana-Farber Partner on Biomaterial for Cancer Immunotherapies Harvard bioengineers' biomaterial-based cancer immunotherapies to be developed by Novartis |
